Skip to main content

Peer Review reports

From: Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review

Original Submission
24 Oct 2023 Submitted Original manuscript
27 Nov 2023 Reviewed Reviewer Report
22 Jan 2024 Reviewed Reviewer Report
21 Feb 2024 Author responded Author comments - Zhouye Song
22 Feb 2024 Author responded Author comments - Zhouye Song
Resubmission - Version 2
21 Feb 2024 Submitted Manuscript version 2
22 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
22 Feb 2024 Editorially accepted
6 Mar 2024 Article published 10.1186/s12885-024-12043-w

You can find further information about peer review here.

Back to article page